메뉴 건너뛰기




Volumn 12, Issue 4, 2005, Pages 295-302

Clinical study to compare the efficacy and adverse effects of Nona Roguy herbal formulation and gonadotrophin releasing hormone agonist (GnRH) in the treatment of uterine fibroids

Author keywords

Adverse effects; Efficacy; Nona roguy herbal formulations; Uterine fibroid

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HEMOGLOBIN; HERBACEOUS AGENT; LEUPRORELIN; LUTEINIZING HORMONE; NONA ROGUY; NONA ROGUY HERBAL PRODUCT; UNCLASSIFIED DRUG;

EID: 30044449255     PISSN: 13412051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (19)
  • 3
    • 30044439865 scopus 로고    scopus 로고
    • Malaysia @
    • Dept. of Statistics Malaysia. (2000). Ringkasan Perangkaan Penting Mengikut Negeri, Malaysia @ http://www.statistics.gov.my/Bahasa/Keysumstats.htm.
    • (2000) Ringkasan Perangkaan Penting Mengikut Negeri
  • 4
    • 0023836712 scopus 로고
    • A Randomized double blind trial of a gonadotrophin releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
    • Friedman A J, Barbieri RL, Doubilet PM, Fine G, Schiff I. (1988). A Randomized double blind trial of a gonadotrophin releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. Fertil Steril, 49, 404-409.
    • (1988) Fertil Steril , vol.49 , pp. 404-409
    • Friedman, A.J.1    Barbieri, R.L.2    Doubilet, P.M.3    Fine, G.4    Schiff, I.5
  • 5
    • 0028064250 scopus 로고
    • Long-term medical therapy for leiomyomata uteri: A prospective randomized study of leuprolide acetate depot plus with the oestrogen-progestin or progestin 'add back' for 2 years
    • Friedman A J, Daly M, Juneau-Norcross M, Gleason R, Rein M S, LeBoff M. (1994). Long-term medical therapy for leiomyomata uteri: a prospective randomized study of leuprolide acetate depot plus with the oestrogen-progestin or progestin 'add back' for 2 years. Hum Reprod, 9, 1618-1625.
    • (1994) Hum Reprod , vol.9 , pp. 1618-1625
    • Friedman, A.J.1    Daly, M.2    Juneau-Norcross, M.3    Gleason, R.4    Rein, M.S.5    Leboff, M.6
  • 6
    • 30044436885 scopus 로고    scopus 로고
    • nd ed. 2003.
    • (2003) nd Ed.
  • 8
    • 0031852917 scopus 로고    scopus 로고
    • Uterine artery embolization for the treatment of uterine fibroids
    • Goodwin S C, Walker W J. (1998). uterine artery embolization for the treatment of uterine fibroids. Curr Opin Obstet Gynecol, 10, 315-320.
    • (1998) Curr Opin Obstet Gynecol , vol.10 , pp. 315-320
    • Goodwin, S.C.1    Walker, W.J.2
  • 9
    • 0026812344 scopus 로고
    • The role of GnRH agonists in treatment of uterine fibroids
    • Healy D L, Vollenhoven B J. (1992). The role of GnRH agonists in treatment of uterine fibroids. Br J Obstet Gynaecol, 99, 23-26.
    • (1992) Br J Obstet Gynaecol , vol.99 , pp. 23-26
    • Healy, D.L.1    Vollenhoven, B.J.2
  • 10
    • 0024548684 scopus 로고
    • Long term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin
    • Matta W H M, Shaw R W, Nye M. (1989). Long term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Brit J Obstet Gynaecol, 96, 200-206.
    • (1989) Brit J Obstet Gynaecol , vol.96 , pp. 200-206
    • Matta, W.H.M.1    Shaw, R.W.2    Nye, M.3
  • 14
    • 0035956680 scopus 로고    scopus 로고
    • Uterine fibroids
    • Stewart E A. (2001). Uterine fibroids. The Lancet, 357, 293-298.
    • (2001) The Lancet , vol.357 , pp. 293-298
    • Stewart, E.A.1
  • 15
    • 0033972112 scopus 로고    scopus 로고
    • Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: A multicentre randomised trial
    • Verspyck E, Marpeau L, Lucas C. (2000). Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial. Eur J Obstet, Gynecol Reprod Biol, 89, 7-13.
    • (2000) Eur J Obstet, Gynecol Reprod Biol , vol.89 , pp. 7-13
    • Verspyck, E.1    Marpeau, L.2    Lucas, C.3
  • 17
    • 0025663426 scopus 로고
    • Clinical predictors of buserelin acetate treatment of uterine fibroids: A prospective study of 40 women
    • Vollenhoven B J, Shekleton P, Mcdonald J, Healy D L. (1990). Clinical predictors of buserelin acetate treatment of uterine fibroids: a prospective study of 40 women. Fertile Steril, 54, 1032-1038.
    • (1990) Fertile Steril , vol.54 , pp. 1032-1038
    • Vollenhoven, B.J.1    Shekleton, P.2    Mcdonald, J.3    Healy, D.L.4
  • 18
    • 0023235830 scopus 로고
    • Shrinkage of uterine fibroids during therapy with goserelen: A luteinizing hormone releasing hormone agonist administered as a monthly subcutaneous depot
    • West C P, Lumsden M A, Lawson S, Williamson J, Baird D T. (1987). Shrinkage of uterine fibroids during therapy with goserelen: a luteinizing hormone releasing hormone agonist administered as a monthly subcutaneous depot. Fertile Steril, 48, 45-51.
    • (1987) Fertile Steril , vol.48 , pp. 45-51
    • West, C.P.1    Lumsden, M.A.2    Lawson, S.3    Williamson, J.4    Baird, D.T.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.